The cell line is not validated yet.
CBCHi001-A-1
General#
Cell Line |
|
hPSCreg Name | CBCHi001-A-1 |
Cell line type | Human induced pluripotent stem cell (hiPSC) |
Last update | 1st April 2022 |
User feedback | |
Provider |
|
Generator | Beijing Chest Hospital (CBCH) |
External Databases |
|
BioSamples | SAMEA13855333 |
General Information |
|
* Is the cell line readily obtainable for third parties? |
Yes Research: allowed
Clinical: not allowed
Commercial: not allowed
|
Subclone of |
Donor Information#
General Donor Information |
|
Sex | female |
Phenotype and Disease related information (Donor) |
|
Diseases | No disease was diagnosed.
|
External Databases (Donor) |
|
BioSamples | SAMEA13855308 |
Ethics#
Also have a look at the ethics information for the parental line
CBCHi001-A
.
For generation of the cell line, who was the supplier of any recombined DNA vectors or commercial kits used? |
hIPSC Derivation#
General |
|
The source cell information can be found in the parental cell line
CBCHi001-A.
|
|
Reprogramming method |
|
Vector type | Non-integrating |
Vector | Sendai virus |
Vector free reprogramming |
|
Other |
|
Derived under xeno-free conditions |
Unknown |
Derived under GMP? |
Unknown |
Available as clinical grade? |
Unknown |
Culture Conditions#
Medium |
mTeSR™ Plus
|
Characterisation#
Analysis of Undifferentiated Cells
Marker | Expressed | Immunostaining | RT-PCR | FACS | Enzymatic Assay | Expression Profiles |
SOX2 |
Yes |
|
||||
SSEA-4 |
Yes |
|
Score:
Marker | Present | Absent |
mCpG | ||
OCT4 |
Differentiation Potency
Genotyping#
Karyotyping (Cell Line) |
|
Other Genotyping (Cell Line) |
Genetic Modification#
Disease/phenotype related modifications |
|
Login to share your feedback, experiences or results with the research community.